Brookstone Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $631K | Sell |
17,521
-87
| -0.5% | -$3.13K | 0.01% | 691 |
|
|
2025
Q1 | $694K | Buy |
17,608
+87
| +0.5% | +$3.43K | 0.01% | 640 |
|
|
2024
Q4 | $527K | Buy |
17,521
+624
| +4% | +$18.8K | 0.01% | 680 |
|
|
2024
Q3 | $395K | Hold |
16,897
| – | – | 0.01% | 753 |
|
|
2024
Q2 | $373K | Buy |
16,897
+30
| +0.2% | +$662 | 0.01% | 729 |
|
|
2024
Q1 | $257K | Hold |
16,867
| – | – | ﹤0.01% | 806 |
|
|
2023
Q4 | $288K | Sell |
16,867
-688
| -4% | -$11.8K | 0.01% | 728 |
|
|
2023
Q3 | $117K | Buy |
17,555
+436
| +3% | +$2.91K | ﹤0.01% | 798 |
|
|
2023
Q2 | $427K | Hold |
17,119
| – | – | 0.01% | 616 |
|
|
2023
Q1 | $352K | Buy |
17,119
+2,919
| +21% | +$60K | 0.01% | 660 |
|
|
2022
Q4 | $153K | Buy |
14,200
+2,475
| +21% | +$26.7K | ﹤0.01% | 788 |
|
|
2022
Q3 | $67K | Buy |
+11,725
| New | +$67K | ﹤0.01% | 762 |
|